KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Accumulated Expenses: 2009-2024

Historic Accumulated Expenses for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $232.0 million.

  • Charles River Laboratories International's Accumulated Expenses rose 27.77% to $269.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $269.7 million, marking a year-over-year increase of 27.77%. This contributed to the annual value of $232.0 million for FY2024, which is 1.84% up from last year.
  • Per Charles River Laboratories International's latest filing, its Accumulated Expenses stood at $232.0 million for FY2024, which was up 1.84% from $227.8 million recorded in FY2023.
  • Over the past 5 years, Charles River Laboratories International's Accumulated Expenses peaked at $246.1 million during FY2021, and registered a low of $206.8 million during FY2020.
  • Over the past 3 years, Charles River Laboratories International's median Accumulated Expenses value was $227.8 million (recorded in 2023), while the average stood at $226.5 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 30.39% in 2020, then decreased by 10.71% in 2022.
  • Charles River Laboratories International's Accumulated Expenses (Yearly) stood at $206.8 million in 2020, then increased by 19.00% to $246.1 million in 2021, then fell by 10.71% to $219.8 million in 2022, then rose by 3.67% to $227.8 million in 2023, then rose by 1.84% to $232.0 million in 2024.